ITER nuclear fusion project faces delay over Trump budget cuts

FILE PHOTO: A crane loads equipments at the construction site of the International Thermonuclear Experimental Reactor (ITER) in Saint-Paul-lez-Durance,Southern France, October 6, 2016.     REUTERS/Jean-Paul Pelissier

US-NUCLEARPOWER-FUSION-PROJECT:ITER nuclear fusion project faces delay over Trump budget cuts

By Geert De Clercq

PARIS (Reuters) - ITER, an international project to build a prototype nuclear fusion reactor in southern France, said it is facing delays if the Trump administration does not reconsider budget cuts.

Seven partners - Europe, the United States, China, India, Japan, Russia and South Korea - launched the International Thermonuclear Experimental Reactor (ITER) 10 years ago but the project has experienced years of delays and budget overruns.

ITER hopes to generate power from a process similar to the nuclear fusion that powers the sun, unlike existing nuclear reactors that produce energy by splitting atoms.

ITER Director-General Bernard Bigot, in Washington for talks with the U.S. administration, said the U.S. 2017 contribution had been cut from a planned $105 million to $50 million and its 2018 contribution from a planned $120 million to $63 million.

The United States has already spent about $1 billion on the prototype reactor and was scheduled to contribute up to another $1.5 billion through 2025, when ITER is scheduled to run a first operational test.

"If we do not respect deadlines in the beginning, we cannot respect them in the end," Bigot told Reuters by telephone.

Bigot said that following a letter from French President Emmanuel Macron to President Donald Trump in August, Trump had asked his administration to reconsider the issue.

"We hope for a decision this weekend or this week," he said.

"If the U.S. does not provide the necessary funds in 2018, then there will be an impact on the entire project," he added.

Earlier this year, ITER's total budget was revised upwards from 18 to 22 billion euros ($21-26 billion), with a U.S. share of nine percent.

The Trump administration is conducting a review of civilian nuclear policy, including research and development, which will inform U.S. policy toward ITER in the future, said Shaylyn Hynes, a spokeswoman for the U.S. Department of Energy.

U.S. Energy Secretary Rick Perry has told Macron that "we understand the history and the scale of the project," she said.

Bigot said that after Trump cut the U.S. energy department's budget, the department reduced funding for the U.S. companies making ITER components.

ITER member countries finance the manufacturing of ITER components via their own national companies. The parts are then shipped to France and assembled on ITER's Cadarache, southern France site.

ITER's main U.S. supplier is California-based General Atomics, which is building its central solenoid, an 18-metre tall pillar-like magnet that will be one of the first components to be installed by 2020.

The project is now half way towards the first test of its super-heated plasma by 2025 and first full-power fusion by 2035.

ITER says nuclear fusion will not produce nuclear waste like traditional nuclear power plants and will be much safer to operate.

But the challenges of replicating the sun's fusion on earth are enormous and critics say that it remains unclear whether the technology will work and can eventually be commercially viable.

(Reporting by Geert De Clercq; Additional reporting by Timothy Gardner in Washington; Editing by Jane Merriman)

Related News

AbbVie cancer drug fails two late-stage trials

Apr 19, 2017

US-ABBVIE-TRIALS:AbbVie cancer drug fails two late-stage trials

Snap shares hit new low in choppy trading as valuation concerns mount

Mar 15, 2017

US-SNAP-STOCKS:Snap shares hit new low in choppy trading as valuation concerns mount

Fiat Chrysler still trying to resolve U.S. diesel emissions issue

Mar 8, 2017

US-FIAT-CHRYSLER-EMISSIONS:Fiat Chrysler still trying to resolve U.S. diesel emissions issue

Peaple also read these

AbbVie cancer drug fails two late-stage trials

Apr 19, 2017

US-ABBVIE-TRIALS:AbbVie cancer drug fails two late-stage trials

Snap shares hit new low in choppy trading as valuation concerns mount

Mar 15, 2017

US-SNAP-STOCKS:Snap shares hit new low in choppy trading as valuation concerns mount

Fiat Chrysler still trying to resolve U.S. diesel emissions issue

Mar 8, 2017

US-FIAT-CHRYSLER-EMISSIONS:Fiat Chrysler still trying to resolve U.S. diesel emissions issue

About Us

Get the latest news and have a look at the innovations and technologies that are shaping the future and changing the world here in Futurally.

Contact us: sales@futurally.com